Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Response to: Â Correspondence on â Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial by Zhao and Huang
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Wei, James Cheng-Chung | - |
| dc.contributor.author | Kim, Tae Hwan | - |
| dc.contributor.author | Kishimoto, Mitsumasa | - |
| dc.contributor.author | Ogusu, Naoki | - |
| dc.contributor.author | Jeong, Haeyoun | - |
| dc.contributor.author | Kobayashi, Shigeto | - |
| dc.date.accessioned | 2023-08-16T07:33:44Z | - |
| dc.date.available | 2023-08-16T07:33:44Z | - |
| dc.date.created | 2021-11-22 | - |
| dc.date.issued | 2023-06 | - |
| dc.identifier.issn | 0003-4967 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/189009 | - |
| dc.description.abstract | [No abstract available] | - |
| dc.language | 영어 | - |
| dc.language.iso | en | - |
| dc.publisher | BMJ Publishing Group | - |
| dc.title | Response to: Â Correspondence on â Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial by Zhao and Huang | - |
| dc.type | Article | - |
| dc.contributor.affiliatedAuthor | Kim, Tae Hwan | - |
| dc.identifier.doi | 10.1136/annrheumdis-2021-220788 | - |
| dc.identifier.scopusid | 2-s2.0-85163265124 | - |
| dc.identifier.wosid | 000726835000001 | - |
| dc.identifier.bibliographicCitation | Annals of the Rheumatic Diseases, v.82, no.7, pp.1 - 2 | - |
| dc.relation.isPartOf | Annals of the Rheumatic Diseases | - |
| dc.citation.title | Annals of the Rheumatic Diseases | - |
| dc.citation.volume | 82 | - |
| dc.citation.number | 7 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 2 | - |
| dc.type.rims | ART | - |
| dc.type.docType | Letter; Early Access | - |
| dc.description.journalClass | 1 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Rheumatology | - |
| dc.relation.journalWebOfScienceCategory | Rheumatology | - |
| dc.subject.keywordAuthor | ankylosing | - |
| dc.subject.keywordAuthor | biological therapy | - |
| dc.subject.keywordAuthor | inflammation | - |
| dc.subject.keywordAuthor | spondylitis | - |
| dc.subject.keywordAuthor | therapeutics | - |
| dc.identifier.url | https://ard.bmj.com/content/early/2021/06/25/annrheumdis-2021-220788 | - |
- Files in This Item
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Kim, Tae Hwan
- COLLEGE OF MEDICINE (DEPARTMENT OF INTERNAL MEDICINE)